Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
164
FDA:164
Drug Approvals
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate
- Approval Date
- May 10, 2025
FDA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
Glenmark to Launch Generic Ropivacaine Anesthesia Drug in US Market
Glenmark Pharmaceuticals' US subsidiary will launch generic Ropivacaine Hydrochloride injection in November 2025, offering a bioequivalent alternative to Fresenius Kabi's Naropin.